stockrow
Friday 6 November 2026
Export MOBI’s income statement to Excel — free account
Mobia Medical, Inc
MOBI Healthcare Medical Devices
Mobia Medical, Inc’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 104.8% from fiscal 2024.
- Revenue
- +175.9%
- EPS
- +96.0%
- Free cash flow
- −18.0%
Quarter to September 2026, against a year earlier
10.96
0.32
−2.84%
Follow MOBI
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 16 | 32 | 48 | +104.8% | 55 | 79 | 117 | +54.1% | |
| Gross margin, % | — | — | — | — | — | — | — | — | 79.59 | 81.07 | 82.87 | +1.5 pt | ||||||
| EBT | — | — | — | — | — | — | — | — | (25) | (46) | (67) | +89.1% | ||||||
| EBT margin, % | — | — | — | — | — | — | — | — | (157.18) | (145.10) | (139.15) | +12.1 pt | ||||||
| Net income | — | — | — | — | — | — | — | — | (25) | (46) | (103) | +89.0% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 27.21 | 37.74 | 1.44 | +38.7% | |||||
| Earnings | — | — | — | — | — | — | — | — | (42.79) | (54.77) | (33.36) | +28.0% | ||||||
| Cash flow | — | — | — | — | — | — | — | — | (42.29) | (53.82) | (2.76) | +27.3% | ||||||
| Capex | — | — | — | — | — | — | — | — | (0.07) | (0.43) | (0.06) | +504.5% | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | (42.36) | (54.25) | (2.82) | +28.1% | ||||||
| Book value | — | — | — | — | — | — | — | — | (184.41) | 34.16 | 0.00 | n/m | ||||||
| Shares, m | — | — | — | — | — | — | — | — | 1 | 1 | 14 | +47.7% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 7.84 | 0.0 | ||||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 2.17 | 0.0 | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 4.64 | 0.0 | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | (0.04) | (0.04) | (2.36) | 0.0 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | (24) | (46) | (92) | +87.9% | |||||
| Capex | — | — | — | — | — | — | — | — | 0 | 0 | (2) | +793.1% | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | (24) | (46) | (94) | +89.1% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | 17 | 36 | 163 | +118.1% | |||||
| Net debt | — | — | — | — | — | — | — | — | (8) | (26) | (161) | +251.5% | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | (106) | 29 | 173 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | 0.00 | (132.40) | (65.55) | (132.4) pt | |||||
| ROIC | — | — | — | — | — | — | — | — | 0.00 | (1,140.09) | 0.00 | (1,140.1) pt | ||||||
| ROE | — | — | — | — | — | — | — | — | 0.00 | 36.21 | 0.00 | +36.2 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | 167 | — | — | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 0.00 | 0.19 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026
Mobia Medical, Inc vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BWAY Brainsway Ltd. Sponsored ADR | $427.1M | 21.2× | — (loss-making) | +35.43% (above 0%: growing) | +40.00% (above 0%: growing) | −51.68% (below 0%: shrinking) | 74.62% | 13.98% | Compare |
| SI Shoulder Innovations, Inc. | $424.1M | — (loss-making) | — (loss-making) | +37.73% (above 0%: growing) | n/m | +38.63% (above 0%: growing) | 78.47% | (46.92%) | Compare |
| RCEL Avita Medical Inc. | $389.5M | — (loss-making) | — (loss-making) | +53.05% (above 0%: growing) | n/m | +86.66% (above 0%: growing) | 84.02% | (17.95%) | Compare |
| SSII SS Innovations International, Inc. | $380.9M | — (loss-making) | — (loss-making) | +39.39% (above 0%: growing) | n/m | −16.62% (below 0%: shrinking) | 50.94% | (16.29%) | Compare |
| MOBI Mobia Medical, Inc | $375.5M | — (loss-making) | — (loss-making) | +175.85% (above 0%: growing) | n/m | −18.01% (below 0%: shrinking) | 83.25% | (118.67%) | |
| OFIX ORTHOFIX MEDICAL INC. | $363.3M | — (loss-making) | — (loss-making) | +3.85% (above 0%: growing) | n/m | −516.58% (below 0%: shrinking) | 70.97% | (3.86%) | Compare |
| VMD Viemed Healthcare, Inc. | $343.2M | 22.0× | 23.4× | +12.18% (above 0%: growing) | +33.33% (above 0%: growing) | −67.55% (below 0%: shrinking) | 57.26% | 0.00% | Compare |
| CV CapsoVision, Inc. | $329.9M | — (loss-making) | — (loss-making) | +9.89% (above 0%: growing) | n/m | −84.44% (below 0%: shrinking) | 51.36% | (208.07%) | Compare |
| CLPT ClearPoint Neuro, Inc. | $278.6M | — (loss-making) | — (loss-making) | +36.27% (above 0%: growing) | n/m | −58.10% (below 0%: shrinking) | 58.46% | (52.44%) | Compare |
| Median of peers | $372.1M | — | — | +35.85% | — | −54.89% | 64.72% | (17.12%) |